browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
ebea61a6-3591-4271-b612-31bfa95d3abe
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 13:34:07
Income (reported)
$60,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

DLA PIPER LLP (US)

Law firm.

Contact
WILLIAM MINOR
Phone
+1 202-799-4312
Address
zip:20004, city:Washington, state:DC, street:500 8th Street, NW
Client

BIOHAVEN PHARMACEUTICALS, INC.

A biopharmaceutical company.

State
CT
Country
US
Effective date
2022-11-01
Issues lobbied + lobbyists (1)

HCR — Health Issues

Policies related to drug approval for treatment of rare diseases. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.

Lobbyists:

Government entities lobbied: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.